litlas
ログインアカウント作成

Scott W. Hiebert

1985–2024 年に発表

95
論文数
20,804
被引用数
77
h 指数
94
i10 指数

被引用数

Scott W. Hiebert の年別被引用数1985 年: 被引用 5 件1986 年: 被引用 11 件1987 年: 被引用 8 件1988 年: 被引用 6 件1989 年: 被引用 8 件1990 年: 被引用 8 件1991 年: 被引用 39 件1992 年: 被引用 151 件1993 年: 被引用 213 件1994 年: 被引用 174 件1995 年: 被引用 191 件1996 年: 被引用 247 件1997 年: 被引用 252 件1998 年: 被引用 357 件1999 年: 被引用 296 件2000 年: 被引用 365 件2001 年: 被引用 292 件2002 年: 被引用 352 件2003 年: 被引用 303 件2004 年: 被引用 315 件2005 年: 被引用 255 件2006 年: 被引用 175 件2007 年: 被引用 145 件2008 年: 被引用 126 件2009 年: 被引用 125 件2010 年: 被引用 110 件2011 年: 被引用 115 件2012 年: 被引用 125 件2013 年: 被引用 130 件2014 年: 被引用 136 件2015 年: 被引用 120 件2016 年: 被引用 125 件2017 年: 被引用 123 件2018 年: 被引用 145 件2019 年: 被引用 407 件2020 年: 被引用 416 件2021 年: 被引用 374 件2022 年: 被引用 310 件2023 年: 被引用 230 件2024 年: 被引用 296 件2025 年: 被引用 114 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,770 件、この内訳の 40.3%中国: 引用元論文 583 件、この内訳の 8.5%イギリス: 引用元論文 472 件、この内訳の 6.9%ドイツ: 引用元論文 387 件、この内訳の 5.6%日本: 引用元論文 324 件、この内訳の 4.7%カナダ: 引用元論文 262 件、この内訳の 3.8%フランス: 引用元論文 231 件、この内訳の 3.3%イタリア: 引用元論文 204 件、この内訳の 3%オランダ: 引用元論文 177 件、この内訳の 2.6%スペイン: 引用元論文 122 件、この内訳の 1.8%オーストラリア: 引用元論文 120 件、この内訳の 1.7%インド: 引用元論文 106 件、この内訳の 1.5%
0%40.3%その他 16.3%

機関

分野

  • Biochemistry, Genetics and Molecular Biology48.7%
  • Medicine41%
  • Immunology and Microbiology7.1%
  • Neuroscience1.7%
  • Agricultural and Biological Sciences0.5%
  • Engineering0.2%
  • その他0.8%

トピック

  • Cancer-related Molecular Pathways5.7%
  • Epigenetics and DNA Methylation5.3%
  • Histone Deacetylase Inhibitors Research4.6%
  • Acute Myeloid Leukemia Research4.6%
  • Protein Degradation and Inhibitors3.3%
  • Ubiquitin and proteasome pathways3%
  • その他73.5%

共著者

全論文

検索で開く
  1. Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system

    著者: Sung Hoon Cho, Ariel Raybuck, Kristy R. Stengel, Wei Mei, Thomas C. Beck, Emmanuel J. Volanakis, James W. Thomas, Scott W. Hiebert, Volker H. Haase, Mark Boothby - Nature 2016 被引用: 315

  2. CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

    著者: Yanwen Jiang, Ana Ortega-Molina, Huimin Geng, Hsia‐Yuan Ying, Katerina Hatzi, Sara Parsa, Dylan McNally, Ling Wang, Ashley S. Doane, Xabier Agirre, Matt Teater, Cem Meydan, Zhuoning Li, David Poloway, Shenqiu Wang, Daisuke Ennishi, David W. Scott, Kristy R. Stengel, Janice E. Kranz, Edward B. Holson, Sneh Sharma, James W. Young, Chi-Shuen Chu, Robert G. Roeder, Rita Shaknovich, Scott W. Hiebert, Randy D. Gascoyne, Wayne Tam, Olivier Elemento, Hans‐Guido Wendel, Ari Melnick - Cancer Discovery 2016 被引用: 272

  3. Analysis of protein dynamics at active, stalled, and collapsed replication forks

    著者: Bianca M. Sirbu, Frank B. Couch, Jordan T. Feigerle, Srividya Bhaskara, Scott W. Hiebert, David Cortez - Genes & Development 2011 被引用: 441

  4. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages

    著者: Xuefen Chen, Iros Barozzi, Alberto Termanini, Elena Prosperini, Antonio Recchiuti, Jesmond Dalli, Flore Mietton, Gianluca Matteoli, Scott W. Hiebert, Gioacchino Natoli - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 396

  5. Myocardial Infarction Activates CCR2+ Hematopoietic Stem and Progenitor Cells

    著者: Partha Dutta, Hendrik B. Sager, Kristy R. Stengel, Kamila Naxerova, Gabriel Courties, Borja Sáez, Lev Silberstein, Timo Heidt, Matthew Sebas, Yuan Sun, Gregory R. Wojtkiewicz, Paolo Fumene Feruglio, Kevin R. King, Joshua N. Baker, Anja M. van der Laan, Anna Borodovsky, Kevin Fitzgerald, Maarten Hulsmans, Friedrich Felix Hoyer, Yoshiko Iwamoto, Claudio Vinegoni, Dennis Brown, Marcelo F. Di Carli, Peter Libby, Scott W. Hiebert, David T. Scadden, Filip K. Świrski, Ralph Weissleder, Matthias Nahrendorf - Cell stem cell 2015 被引用: 217

  6. Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity

    著者: Erin R. Aho, Jing Wang, Rocco D. Gogliotti, Gregory C. Howard, Jason Phan, Pankaj Acharya, Jonathan D. Macdonald, Ken Cheng, Shelly L. Lorey, Bin Lü, Sabine Wenzel, Audra F. Bryan, Joseph Alvarado, Feng Wang, J. Grace Shaw, Bin Zhao, April M. Weissmiller, Lance R. Thomas, Christopher R. Vakoc, Matthew D. Hall, Scott W. Hiebert, Qi Liu, Shaun R. Stauffer, Stephen W. Fesik, William P. Tansey - Cell Reports 2019 被引用: 123

  7. Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control

    著者: Srividya Bhaskara, Brenda Chyla, Joseph M. Amann, Sarah K. Knutson, David Cortez, Zu-Wen Sun, Scott W. Hiebert - Molecular Cell 2008 被引用: 382

  8. Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability

    著者: Srividya Bhaskara, Sarah K. Knutson, Guochun Jiang, Mahesh B. Chandrasekharan, Andrew J. Wilson, Siyuan Zheng, Ashwini Yenamandra, Kimberly Locke, Jia-ling Yuan, Alyssa R. Bonine-Summers, Christina E. Wells, Jonathan F. Kaiser, M. Kay Washington, Zhongming Zhao, Florence F. Wagner, Zu-Wen Sun, Fen Xia, Edward B. Holson, Dineo Khabele, Scott W. Hiebert - Cancer Cell 2010 被引用: 359

  9. Human SMARCA5 is continuously required to maintain nucleosome spacing

    著者: Monica Bomber, Jing Wang, Qi Liu, Kelly R. Barnett, Hillary M. Layden, Emily Hodges, Kristy R. Stengel, Scott W. Hiebert - Molecular Cell 2023 被引用: 51

  10. The E2F transcription factor is a cellular target for the RB protein

    著者: Srikumar Chellappan, Scott W. Hiebert, Maria Mudryj, Jonathan M. Horowitz, Joseph R. Nevins - Cell 1991 被引用: 1,449

  11. Liver‐specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks

    著者: Sarah K. Knutson, Brenda Chyla, Joseph M. Amann, Srividya Bhaskara, Stacey S. Huppert, Scott W. Hiebert - The EMBO Journal 2008 被引用: 266

  12. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB

    著者: Elisabeth Ziesché, Daniela Kettner-Buhrow, Axel Weber, Tobias Wittwer, Liane Jurida, Johanna Soelch, Helmut Müller, Doris Newel, Petra Kronich, Heike Schneider, Oliver Dittrich‐Breiholz, Srividya Bhaskara, Scott W. Hiebert, Michael O. Hottiger, Haiying Li, Ezra Burstein, M. Lienhard Schmitz, Michael Kracht - Nucleic Acids Research 2012 被引用: 123

  13. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3

    著者: Liqing Wang, Yujie Liu, Rongxiang Han, Ulf H. Beier, Tricia Bhatti, Tatiana Akimova, Mark I. Greene, Scott W. Hiebert, Wayne W. Hancock - Journal of Clinical Investigation 2015 被引用: 102

  14. Definition of a small core transcriptional circuit regulated by AML1-ETO

    著者: Kristy R. Stengel, Jacob Ellis, Clare Spielman, Monica Bomber, Scott W. Hiebert - Molecular Cell 2020 被引用: 75

  15. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

    著者: Jun‐ya Kato, H Matsushime, Scott W. Hiebert, Mark E. Ewen, C J Sherr - Genes & Development 1993 被引用: 1,278

  16. A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters

    著者: Katerina Hatzi, Yanwen Jiang, Chuanxin Huang, Francine E. Garrett-Bakelman, Micah D. Gearhart, Ευγενία Γιαννοπούλου, Paul Zumbo, Kevin N. Kirouac, Srividya Bhaskara, José M. Polo, Matthías Kormáksson, Alexander D. MacKerell, Fengtian Xue, Christopher E. Mason, Scott W. Hiebert, Gilbert G. Privé, Leandro Cerchietti, Vivian J. Bardwell, Olivier Elemento, Ari Melnick - Cell Reports 2013 被引用: 196

  17. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis

    著者: Tsukasa Okuda, Jan M. van Deursen, Scott W. Hiebert, Gerard C. Grosveld, James R. Downing - Cell 1996 被引用: 1,864

  18. Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors

    著者: Johanna M. Schafer, Brian D. Lehmann, Paula I. González-Ericsson, Clayton B. Marshall, J. Scott Beeler, Lindsay N. Redman, Hailing Jin, Violeta Sánchez, Matthew C. Stubbs, Peggy Scherle, Kimberly N. Johnson, Quanhu Sheng, Joseph T. Roland, Joshua A. Bauer, Yu Shyr, Bapsi Chakravarthy, Bret C. Mobley, Scott W. Hiebert, Justin M. Balko, Melinda E. Sanders, Phillip C.C. Liu, Jennifer A. Pietenpol - Science Translational Medicine 2020 被引用: 73

  19. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.

    著者: Scott W. Hiebert, Srikumar Chellappan, Jordan M. Horowitz, Joseph R. Nevins - Genes & Development 1992 被引用: 593

  20. Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells

    著者: Kyungsoo Ha, Warren Fiskus, Dong Soon Choi, Srividya Bhaskara, Leandro Cerchietti, Santhana G.T. Devaraj, Bhavin Shah, Sunil Sharma, Jenny C. Chang, Ari Melnick, Scott W. Hiebert, Kapil N. Bhalla - Oncotarget 2014 被引用: 160

  21. The CDK7 inhibitor THZ1 alters RNA polymerase dynamics at the 5′ and 3′ ends of genes

    著者: Shilpa Sampathi, Pankaj Acharya, Yue Zhao, Jing Wang, Kristy R. Stengel, Qi Liu, Michael R. Savona, Scott W. Hiebert - Nucleic Acids Research 2019 被引用: 44

  22. PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets

    著者: Susu Zhang, Jing Wang, Qi Liu, W. Hayes McDonald, Monica Bomber, Hillary M. Layden, Jacob Ellis, Scott C. Borinstein, Scott W. Hiebert, Kristy R. Stengel - Molecular Cell 2022 被引用: 35

  23. Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation

    著者: Jing Wang, Yue Zhao, Xiaofan Zhou, Scott W. Hiebert, Qi Liu, Yu Shyr - BMC Genomics 2018 被引用: 79

  24. High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML

    著者: Yue Zhao, Qi Liu, Pankaj Acharya, Kristy R. Stengel, Quanhu Sheng, Xiaofan Zhou, Hojoong Kwak, Melissa A. Fischer, James E. Bradner, Stephen A. Strickland, Sanjay Mohan, Michael R. Savona, Bryan J. Venters, Ming-Ming Zhou, John T. Lis, Scott W. Hiebert - Cell Reports 2016 被引用: 75